About PathCision Medicine
PathCision Medicine is a private company based in Watertown, Massachusetts, incorporated in 2022 in Delaware. It has reported $2,300,000 raised in two offerings on Form D since February 2024. Its chief executive is Hui-Hsuan Wang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2022 | Feb 21, 2024amended Feb 5, 2026 | $1,700,000of $3.0M target | 8 | $212K | Equity, S.A.F.E. (Simple Agreement for Future Equity)Rule 506(b) | Form D/A ↗1 earlier filing |
| Nov 10, 2022 | Dec 30, 2022 | $600,000of $1.0M target | 3 | $200K | Equity, S.A.F.E. (Simple Agreement for Future Equity)Rule 506(b) | Form D ↗ |
| Total, two offerings | $2,300,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PathCision Medicine's Form D filed Feb 5, 2026.
HW
Hui-Hsuan Wang
Chief Executive Officer and director
YL
Yang Lee
Executive officer and director